Noman laboratory also revealed that targeting VPS34 in animal models turns cold tumors into hot, inflamed tumors in melanoma and CRC, thus enhancing the efficacy of anti-programmed death-ligand 1 (PD-L1)/programmed cell death-1 (PD-1) blockade [60]. Here, PDCD1 is linked to melanoma.